MX2023000850A - Particulas polimericas de poli(amina-co-ester) para la liberacion pulmonar selectiva. - Google Patents
Particulas polimericas de poli(amina-co-ester) para la liberacion pulmonar selectiva.Info
- Publication number
- MX2023000850A MX2023000850A MX2023000850A MX2023000850A MX2023000850A MX 2023000850 A MX2023000850 A MX 2023000850A MX 2023000850 A MX2023000850 A MX 2023000850A MX 2023000850 A MX2023000850 A MX 2023000850A MX 2023000850 A MX2023000850 A MX 2023000850A
- Authority
- MX
- Mexico
- Prior art keywords
- amine
- poly
- ester
- methods
- delivery
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 2
- 230000002685 pulmonary effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 231100001231 less toxic Toxicity 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000012096 transfection reagent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063057626P | 2020-07-28 | 2020-07-28 | |
| US17/332,175 US20220031633A1 (en) | 2020-07-28 | 2021-05-27 | Poly(amine-co-ester) polymeric particles for selective pulmonary delivery |
| PCT/US2021/043514 WO2022026585A1 (en) | 2020-07-28 | 2021-07-28 | Poly(amine-co-ester) polymeric particles for selective pulmonary delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023000850A true MX2023000850A (es) | 2023-02-15 |
Family
ID=80002419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023000850A MX2023000850A (es) | 2020-07-28 | 2021-07-28 | Particulas polimericas de poli(amina-co-ester) para la liberacion pulmonar selectiva. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220031633A1 (https=) |
| EP (1) | EP4188342A1 (https=) |
| JP (1) | JP2023536119A (https=) |
| KR (1) | KR20230047126A (https=) |
| CN (1) | CN116137812A (https=) |
| AU (1) | AU2021315545A1 (https=) |
| BR (1) | BR112023001379A2 (https=) |
| CA (1) | CA3185957A1 (https=) |
| MX (1) | MX2023000850A (https=) |
| WO (1) | WO2022026585A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021293780A1 (en) | 2020-06-19 | 2023-02-02 | Yale University | Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9126677D0 (en) | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9400411D0 (en) | 1994-01-11 | 1994-03-09 | Johnson Matthey Plc | Improvements in chemical compounds |
| MXPA03000905A (es) | 2000-08-02 | 2003-06-24 | Slil Biomedical Corp | Compuestos de poliamina ciclicos como tratamiento contra el cancer. |
| CA2429814C (en) | 2000-12-01 | 2014-02-18 | Thomas Tuschl | Rna interference mediating small rna molecules |
| WO2009114614A2 (en) | 2008-03-11 | 2009-09-17 | Yale University | Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| US8883819B2 (en) * | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| US9895451B2 (en) | 2011-12-02 | 2018-02-20 | Yale University | Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof |
| US10465042B2 (en) | 2011-12-02 | 2019-11-05 | Yale University | Poly(amine-co-ester) nanoparticles and methods of use thereof |
| US9272043B2 (en) * | 2011-12-02 | 2016-03-01 | Yale University | Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery |
| WO2013082529A1 (en) | 2011-12-02 | 2013-06-06 | Yale University | Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery |
| US20210189062A1 (en) | 2016-03-01 | 2021-06-24 | Alexion Pharmaceuticals, Inc. | Biodegradable activated polymers for therapeutic delivery |
| WO2017197128A1 (en) | 2016-05-11 | 2017-11-16 | Yale University | Poly(amine-co-ester) nanoparticles and methods of use thereof |
| CA3041679A1 (en) * | 2016-10-27 | 2018-05-03 | Lawrence S. ZISMAN | Combination therapy for treating pulmonary hypertension |
-
2021
- 2021-05-27 US US17/332,175 patent/US20220031633A1/en not_active Abandoned
- 2021-07-28 EP EP21758881.3A patent/EP4188342A1/en active Pending
- 2021-07-28 JP JP2023505918A patent/JP2023536119A/ja active Pending
- 2021-07-28 CA CA3185957A patent/CA3185957A1/en active Pending
- 2021-07-28 KR KR1020237005841A patent/KR20230047126A/ko active Pending
- 2021-07-28 WO PCT/US2021/043514 patent/WO2022026585A1/en not_active Ceased
- 2021-07-28 CN CN202180059479.4A patent/CN116137812A/zh active Pending
- 2021-07-28 AU AU2021315545A patent/AU2021315545A1/en active Pending
- 2021-07-28 MX MX2023000850A patent/MX2023000850A/es unknown
- 2021-07-28 BR BR112023001379A patent/BR112023001379A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA3185957A1 (en) | 2022-02-03 |
| WO2022026585A1 (en) | 2022-02-03 |
| KR20230047126A (ko) | 2023-04-06 |
| EP4188342A1 (en) | 2023-06-07 |
| BR112023001379A2 (pt) | 2023-02-14 |
| US20220031633A1 (en) | 2022-02-03 |
| AU2021315545A1 (en) | 2023-02-16 |
| JP2023536119A (ja) | 2023-08-23 |
| CN116137812A (zh) | 2023-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | Supramolecular anchoring of DNA polyplexes in cyclodextrin-based polypseudorotaxane hydrogels for sustained gene delivery | |
| Wong et al. | PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo | |
| Xu et al. | Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles | |
| BR112022025855A2 (pt) | Polímero, método de administração de um ou mais agentes de ácido nucleico terapêuticos, de diagnóstico ou profiláticos, ou combinações dos mesmos in vivo | |
| Smith et al. | Diblock glycopolymers promote colloidal stability of polyplexes and effective pDNA and siRNA delivery under physiological salt and serum conditions | |
| Zhang et al. | Poly (β-amino ester) s-based nanovehicles: Structural regulation and gene delivery | |
| Durmaz et al. | Development of Degradable, pH‐Sensitive Star Vectors for Enhancing the Cytoplasmic Delivery of Nucleic Acids | |
| Liu et al. | Biophysical characterization of hyper-branched polyethylenimine-graft-polycaprolactone-block-mono-methoxyl-poly (ethylene glycol) copolymers (hy-PEI-PCL-mPEG) for siRNA delivery | |
| US20150283254A1 (en) | Polymeric nanoparticles | |
| CN101270168B (zh) | 透明质酸接枝聚乙烯亚胺共聚物、制备方法及其作为基因载体的应用 | |
| Pezzoli et al. | Chitosan-graft-branched polyethylenimine copolymers: influence of degree of grafting on transfection behavior | |
| Ren et al. | Charge density and molecular weight of polyphosphoramidate gene carrier are key parameters influencing its DNA compaction ability and transfection efficiency | |
| Buerkli et al. | Amphipathic homopolymers for siRNA delivery: probing impact of bifunctional polymer composition on transfection | |
| Li et al. | Series of new β-cyclodextrin-cored starlike carriers for gene delivery | |
| Cheng et al. | Cyclodextrin‐Based Star‐Like Amphiphilic Cationic Polymer as a Potential Pharmaceutical Carrier in Macrophages | |
| Sun et al. | Self-assembled pH-sensitive polymeric nanoparticles for the inflammation-targeted delivery of Cu/Zn-superoxide dismutase | |
| Zhang et al. | PEGylated poly (amine-co-ester) micelles as biodegradable non-viral gene vectors with enhanced stability, reduced toxicity and higher in vivo transfection efficacy | |
| KR20160091938A (ko) | 믹토-암 가지형 폴리머 | |
| El Jundi et al. | Degradable double hydrophilic block copolymers and tripartite polyionic complex micelles thereof for small interfering ribonucleic acids (siRNA) delivery | |
| Hu et al. | Degradation and degradation-induced re-assembly of PVP-PCL micelles | |
| CN116789961B (zh) | 内质网靶向单链环状聚(β-氨基酯)及制备方法和应用 | |
| Gunbas et al. | Semi-IPN chitosan/PEG microspheres and films for biomedical applications: characterization and sustained release optimization | |
| Zhu et al. | Efficient poly (N-3-hydroxypropyl) aspartamide-based carriers via ATRP for gene delivery | |
| CN102492095B (zh) | Atrp法构建以多糖为骨架的生物可还原高效阳离子基因载体 | |
| CN102702407A (zh) | Atrp法构建以pgma为骨架的阳离子基因载体 |